Screener / SEC EDGAR /CIK 0001038074 /10-K filed Feb 10, 2026, compared with Feb 4, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Technology · Semiconductors

Silicon Laboratories Inc. SLAB

Compare with peers Embed
Earnings releases

Latest results release: Nov 10, 2026

8-K item 2.02, exhibit 99

What SLAB's management wrote with each quarter's results: the press release and, when the company files them, its prepared remarks or the call transcript. The call itself is not filed with SEC, so most quarters have the release only.

Adjusted vs GAAP earnings per share

In the company's own words · read from each release, never computed

In its release of Aug 11, 2026, SLAB reported −$0.32 per share under GAAP and $0.71 on its own adjusted basis.

GAAP EPS $-1.89, release Feb 7, 2024: a GAAP basis: · GAAP gross margin to be 52% · GAAP operating expenses of approximately $118 million · GAAP diluted loss per share between $(1.89) to $(2.05) On a non-GAAP basis, excludi Adjusted EPS $-0.92, release Feb 7, 2024: tables: · Non-GAAP gross margin to be 52% · Non-GAAP operating expenses of approximately $96 million · Non-GAAP diluted loss per share between $(0.92) to $(1.04) Earnings Webcast and Confere 2024-02 GAAP EPS $-0.32, release Aug 11, 2026: GAAP diluted loss per share was $(0.32), improving by 52% over the comparable period last year Adjusted EPS $0.71, release Aug 11, 2026: Non-GAAP diluted earnings per share was $0.71, up 545% over the comparable period last year Results on a GAAP basis: 2026-08
GAAP EPSAdjusted EPS, as the company defines itThe figure on top is how far adjusted is from GAAP. Click a bar for the sentence.
ReleaseGAAP EPSAdjusted EPSGap
Aug 11, 2026 -0.32 0.71 –
Feb 7, 2024 -1.89 -0.92 –
The company's words, latest release
GAAP diluted loss per share was $(0.32), improving by 52% over the comparable period last year release
Non-GAAP diluted earnings per share was $0.71, up 545% over the comparable period last year Results on a GAAP basis: release

Both numbers are read from the words of each release (usually the highlights), never computed by us; hover a number for its sentence. Quarters where the release gives them only in a table are not shown. The company decides what "adjusted" leaves out; the full reconciliation is in the release.

Read and search

Every release, in full · linked to sec.gov

Press release Nov 10, 2026 · EX-99

Silicon Labs Reports Third Quarter 2026 Results

Open on SEC

Silicon Labs (NASDAQ: SLAB), the leading innovator in low-power wireless, reported financial results for the third quarter, which ended October 3, 2026.

“We delivered strong third-quarter results, with revenue up 10% sequentially, underpinned by broad-based growth across many end applications and another record quarter for medical revenue as known customer ramps continued,” said Matt Johnson, President and Chief Executive Officer. “Earnings significantly outpaced revenue growth, a result of strong operational execution by the team. Looking ahead, our current backlog and design-win ramps position us for continued revenue growth and meaningful earnings expansion.”

• Bookings imply a healthy demand environment, while distributor inventory declined further to a multi-year low and end customer inventory was near record lows during the quarter

• Medical revenue reached a new quarterly record, increasing 48% sequentially and more than 300% year-over-year

• GAAP diluted earnings per share was $0.26, compared with a loss of $0.30 in the year-ago quarter

• Non-GAAP diluted earnings per share was $1.05, up 228% over the comparable period last year

Results on a non-GAAP basis, excluding the impact of stock compensation, amortization of acquired intangible assets, merger-related costs, and certain other items as set forth in the below GAAP to Non-GAAP reconciliation tables were as follows:

Due to the announced pending acquisition of Silicon Labs by Texas Instruments, Silicon Labs has suspended providing forward-looking guidance.

Silicon Labs (NASDAQ: SLAB) is the leading innovator in low-power wireless connectivity, building embedded technology that connects devices and improves lives. Merging cutting-edge technology into the world's most highly integrated SoCs, Silicon Labs provides device makers the solutions, support, and ecosystems needed to create advanced edge connectivity applications. Headquartered in Austin, Texas, Silicon Labs has operations in over 16 countries and is the

trusted partner for innovative solutions in the smart home, industrial IoT, and smart cities markets. Learn more at silabs.com.

This press release contains forward-looking statements regarding Silicon Labs’ current expectations, which are based on its current views and assumptions. The words “believe”, “estimate”, “expect”, “intend”, “anticipate”, “plan”, “project”, “will”, and similar phrases as they relate to Silicon Labs are intended to identify such forward-looking statements, although the absence of such words does not necessarily mean a statement is not forward looking. These forward-looking statements include, but are not necessarily limited to, Silicon Labs’ expectations regarding its near- and long-term strength and continued revenue growth and earnings expansion and are subject to various risks and uncertainties that could cause actual results to differ materially from expectations that are expressed or implied herein. Among the factors that could cause actual results to differ materially from those in the forward-looking statements are the following: our ability to complete the merger with Texas Instruments within the time frame expected, or at all, as well as potential disruptions in our business and restrictions on our activities during the pendency of the merger; fluctuating changes in global trade policies, including the imposition of tariffs, duties, trade sanctions, or other barriers to international commerce; the impact of the current global memory chip shortage; the competitive and cyclical nature of the semiconductor industry; the challenging macroeconomic environment, including disruptions in the financial services industry; geographic concentration of manufacturers, assemblers, test service providers and customers in Asia that subjects Silicon Labs’ business and results of operations to risks of natural disasters, epidemics or pandemics, war and political unrest; risks that demand and the supply chain may be adversely affected by military conflict (including in the Middle East, and between Russia and Ukraine), terrorism, sanctions or other geopolitical events globally (including in the Middle East, and conflict between Taiwan and China); risks that Silicon Labs may not be able to maintain its historical growth; quarterly fluctuations in revenues and operating results; difficulties developing new products that achieve market acceptance; risks associated with international activities (including trade barriers, particularly with respect to China); intellectual property litigation risks; risks associated with acquisitions and divestitures; product liability risks; difficulties managing and/or obtaining sufficient supply from Silicon Labs’ distributors, manufacturers and subcontractors; dependence on a limited number of products; absence of long-term commitments from customers; inventory-related risks; difficulties managing international activities; risks that Silicon Labs may not be able to manage strains associated with its growth; credit risks associated with its accounts receivable; dependence on key personnel; stock price volatility; the impact of public health crises on the U.S. and global economy; debt-related risks; capital-raising risks; the timing and scope of share repurchases and/or dividends; average selling prices of products may decrease significantly and rapidly; information technology risks; cyber-attacks against Silicon Labs’ products and its networks; risks associated with any material weakness in our internal controls over financial reporting; risks relating to compliance with laws and regulations; and other factors that are detailed in the SEC filings of Silicon Laboratories Inc. Silicon Labs disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. References in this press release to Silicon Labs shall mean Silicon Laboratories Inc.

Note to editors: Silicon Laboratories, Silicon Labs, the “S” symbol, and the Silicon Labs logo are trademarks of Silicon Laboratories Inc. All other product names noted herein may be trademarks of their respective holders.

For more information: Silicon Labs Investor Relations, [email protected]

In addition to the GAAP results provided throughout this document, Silicon Labs has provided non-GAAP financial measurements on a basis excluding non-cash and other charges and benefits. Details of these excluded items are presented in the tables below, which reconcile the GAAP results to non-GAAP financial measurements.

The non-GAAP financial measurements do not replace the presentation of Silicon Labs’ GAAP financial results. These measurements provide supplemental information to assist management and investors in analyzing Silicon Labs’ financial position and results of operations. Silicon Labs has chosen to provide this information to investors to enable them to perform meaningful comparisons of past, present and future operating results and as a means to emphasize the results of core on-going operations. Unaudited Reconciliation of GAAP to Non-GAAP Financial Measures

October 3, January 3, 2026 2026 ─────────────────────────────────────────────────────────────────────────── Assets Current assets: Cash and cash equivalents $ 423,013 $ 364,222 Short-term investments 16,828 79,400 Accounts receivable, net 79,966 64,513 Inventories 133,391 95,566 Prepaid expenses and other current 71,421 70,316 assets Total current assets 724,619 674,017 Property and equipment, net 131,687 128,643 Goodwill 376,389 376,389 Other intangible assets, net 16,246 23,130 Other assets, net 87,213 67,138 Total assets $ 1,336,154 $ 1,269,317 Liabilities and Stockholders’ Equity Current liabilities: Accounts payable $ 68,860 $ 50,717 Deferred revenue and returns liability 9,804 5,359 Other current liabilities 78,841 87,711 Total current liabilities 157,505 143,787 Other non-current liabilities 53,267 31,112 Total liabilities 210,772 174,899 Commitments and contingencies Stockholders’ equity: Preferred stock – $0.0001 par value; 10,000 shares authorized; no shares — — issued Common stock – $0.0001 par value; 250,000 shares authorized; 33,384 and 32,955 shares issued and outstanding at 3 3 October 3, 2026 and January 3, 2026, respectively Additional paid-in capital 206,203 157,402 Retained earnings 919,176 936,814 Accumulated other comprehensive income — 199 Total stockholders’ equity 1,125,382 1,094,418 Total liabilities and stockholders’ $ 1,336,154 $ 1,269,317 equity

October 3, October 4, Nine Months Ended 2026 2025 ────────────────────────────────────────────────────────────────────────────── Operating Activities Net loss $ -17,638 $ -62,223 Adjustments to reconcile net loss to net cash provided by operating activities: Depreciation of property 18,154 18,769 and equipment Amortization of other 6,884 11,074 intangible assets Stock-based compensation 69,754 59,645 expense Deferred income taxes 2,164 2,026 Changes in operating assets and liabilities: Accounts receivable -15,453 -12,829 Inventories -37,828 23,316 Prepaid expenses and other -35,213 9,080 assets Accounts payable 18,373 11,141 Other current liabilities and income 3,271 29,901 taxes Deferred revenue and 4,445 5,374 returns liability Other non-current 20,285 -7,916 liabilities Net cash provided by operating 37,198 87,358 activities Investing Activities Purchases of marketable — -34,790 securities Sales of marketable — 15,332 securities Maturities of marketable 62,309 22,598 securities Purchases of property and -28,472 -19,942 equipment Proceeds from capital-related government 8,705 — incentives Purchase of other — -4,000 investment Net cash provided by (used in) investing 42,542 -20,802 activities Financing Activities Payment of taxes withheld for vested -28,710 -14,907 stock awards Proceeds from the issuance of common 7,761 8,147 stock Net cash used in financing -20,949 -6,760 activities Increase in cash and cash 58,791 59,796 equivalents Cash and cash equivalents at beginning 364,222 281,607 of period Cash and cash equivalents at end of $ 423,013 $ 341,403 period

Full text with the tables
                                                                                
  Exhibit 99                                                                    
                                                                                
                                                                                
                Silicon Labs Reports Third Quarter 2026 Results                 
                                                                                
Wireless IoT leader delivers $251 million in revenue and strong earnings growth 
                                                                                
  AUSTIN, Texas – November 10, 2026 –                                           
                                                                                
Silicon Labs (NASDAQ: SLAB), the leading innovator in low-power wireless,
reported financial results for the third quarter, which ended October 3, 2026.

“We delivered strong third-quarter results, with revenue up 10% sequentially,
underpinned by broad-based growth across many end applications and another
record quarter for medical revenue as known customer ramps continued,” said Matt
Johnson, President and Chief Executive Officer. “Earnings significantly outpaced
revenue growth, a result of strong operational execution by the team. Looking
ahead, our current backlog and design-win ramps position us for continued
revenue growth and meaningful earnings expansion.”
                                                                                
   Third Quarter Financial Highlights                                           
                                                                                
• Revenue was $251 million, up 22% year-over-year

• Industrial & Commercial revenue was $141 million, up 20% year-over-year

• Home & Life revenue was $110 million, up 24% year-over-year

• Bookings imply a healthy demand environment, while distributor inventory
declined further to a multi-year low and end customer inventory was near record
lows during the quarter

• Medical revenue reached a new quarterly record, increasing 48% sequentially
and more than 300% year-over-year

• GAAP diluted earnings per share was $0.26, compared with a loss of $0.30 in
the year-ago quarter

• Non-GAAP diluted earnings per share was $1.05, up 228% over the comparable
period last year

Results on a GAAP basis:

• GAAP gross margin was 60.8%

• GAAP operating expenses were $145 million

• GAAP operating income was $8 million

• GAAP diluted earnings per share was $0.26

Results on a non-GAAP basis, excluding the impact of stock compensation,
amortization of acquired intangible assets, merger-related costs, and certain
other items as set forth in the below GAAP to Non-GAAP reconciliation tables
were as follows:

• Non-GAAP gross margin was 61.0%

• Non-GAAP operating expenses were $113 million

• Non-GAAP operating income was $40 million

• Non-GAAP diluted earnings per share was $1.05

Due to the announced pending acquisition of Silicon Labs by Texas Instruments,
Silicon Labs has suspended providing forward-looking guidance.
                                                                                
  About Silicon Labs                                                            
                                                                                
Silicon Labs (NASDAQ: SLAB) is the leading innovator in low-power wireless
connectivity, building embedded technology that connects devices and improves
lives. Merging cutting-edge technology into the world's most highly integrated
SoCs, Silicon Labs provides device makers the solutions, support, and ecosystems
needed to create advanced edge connectivity applications. Headquartered in
Austin, Texas, Silicon Labs has operations in over 16 countries and is the

trusted partner for innovative solutions in the smart home, industrial IoT, and
smart cities markets. Learn more at silabs.com.
                                                                                
  Forward-Looking Statements                                                    
                                                                                
This press release contains forward-looking statements regarding Silicon Labs’
current expectations, which are based on its current views and assumptions. The
words “believe”, “estimate”, “expect”, “intend”, “anticipate”, “plan”,
“project”, “will”, and similar phrases as they relate to Silicon Labs are
intended to identify such forward-looking statements, although the absence of
such words does not necessarily mean a statement is not forward looking. These
forward-looking statements include, but are not necessarily limited to, Silicon
Labs’ expectations regarding its near- and long-term strength and continued
revenue growth and earnings expansion and are subject to various risks and
uncertainties that could cause actual results to differ materially from
expectations that are expressed or implied herein. Among the factors that could
cause actual results to differ materially from those in the forward-looking
statements are the following: our ability to complete the merger with Texas
Instruments within the time frame expected, or at all, as well as potential
disruptions in our business and restrictions on our activities during the
pendency of the merger; fluctuating changes in global trade policies, including
the imposition of tariffs, duties, trade sanctions, or other barriers to
international commerce; the impact of the current global memory chip shortage;
the competitive and cyclical nature of the semiconductor industry; the
challenging macroeconomic environment, including disruptions in the financial
services industry; geographic concentration of manufacturers, assemblers, test
service providers and customers in Asia that subjects Silicon Labs’ business and
results of operations to risks of natural disasters, epidemics or pandemics, war
and political unrest; risks that demand and the supply chain may be adversely
affected by military conflict (including in the Middle East, and between Russia
and Ukraine), terrorism, sanctions or other geopolitical events globally
(including in the Middle East, and conflict between Taiwan and China); risks
that Silicon Labs may not be able to maintain its historical growth; quarterly
fluctuations in revenues and operating results; difficulties developing new
products that achieve market acceptance; risks associated with international
activities (including trade barriers, particularly with respect to China);
intellectual property litigation risks; risks associated with acquisitions and
divestitures; product liability risks; difficulties managing and/or obtaining
sufficient supply from Silicon Labs’ distributors, manufacturers and
subcontractors; dependence on a limited number of products; absence of long-term
commitments from customers; inventory-related risks; difficulties managing
international activities; risks that Silicon Labs may not be able to manage
strains associated with its growth; credit risks associated with its accounts
receivable; dependence on key personnel; stock price volatility; the impact of
public health crises on the U.S. and global economy; debt-related risks;
capital-raising risks; the timing and scope of share repurchases and/or
dividends; average selling prices of products may decrease significantly and
rapidly; information technology risks; cyber-attacks against Silicon Labs’
products and its networks; risks associated with any material weakness in our
internal controls over financial reporting; risks relating to compliance with
laws and regulations; and other factors that are detailed in the SEC filings of
Silicon Laboratories Inc. Silicon Labs disclaims any intention or obligation to
update or revise any forward-looking statements, whether as a result of new
information, future events, or otherwise, except as required by law. References
in this press release to Silicon Labs shall mean Silicon Laboratories Inc.

Note to editors: Silicon Laboratories, Silicon Labs, the “S” symbol, and the
Silicon Labs logo are trademarks of Silicon Laboratories Inc. All other product
names noted herein may be trademarks of their respective holders.

For more information: Silicon Labs Investor Relations,
[email protected]
                                                                                
                           Silicon Laboratories Inc.                            
                                                                                
                                                                                
                Condensed Consolidated Statements of Operations                 
                                                                                
                     (In thousands, except per share data)                      
                                                                                
                                  (Unaudited)                                   
                                                                                
         Thr…  Oct…             Oct…          Nine  Oct…             Oct…       
         Mon…    3,               4,          Mon…    3,               4,       
         End…  2026             2025          End…  2026             2025       
 ────────────────────────────────────────────────────────────────────────────── 
  Re…    $     250…          $  205…          $     692…          $  576…       
  Co…                                                                           
  of           98,…             86,…                272…             251…       
  re…                                                                           
  Gr…          152…             119…                420…             324…       
  pr…                                                                           
  Op…                                                                           
  ex…                                                                           
  Re…                                                                           
  and          93,…             87,…                276…             263…       
  de…                                                                           
  Se…                                                                           
  ge…          51,…             43,…                163…             128…       
  and                                                                           
  ad…                                                                           
  Op…          144…             131…                440…             392…       
  ex…                                                                           
  Op…                                                                           
  in…          7,9…             -12…                -19…             -67…       
  (l…                                                                           
  Ot…                                                                           
  in…                                                                           
  (e…                                                                           
  In…                                                                           
  in…                                                                           
  and          3,1…             3,0…                9,3…             10,…       
  ot…                                                                           
  net                                                                           
  In…          -226             -226                -709             -761       
  ex…                                                                           
  In…                                                                           
  (l…                                                                           
  be…          10,…             -9,…                -11…             -57…       
  in…                                                                           
  ta…                                                                           
  Pr…                                                                           
  for          2,0…              414                6,4…             4,8…       
  in…                                                                           
  ta…                                                                           
  Net                                                                           
  in…    $     8,8…          $  -9,…          $     -17…          $  -62…       
  (l…                                                                           
  Ea…                                                                           
  (l…                                                                           
  per                                                                           
  sh…                                                                           
  Ba…    $     0.27          $  -0.…          $     -0.…          $  -1.…       
  Di…    $     0.26          $  -0.…          $     -0.…          $  -1.…       
  We…                                                                           
  co…                                                                           
  sh…                                                                           
  ou…                                                                           
  Ba…                33,…             32,…                33,…             32…  
  Di…                33,…             32,…                33,…             32…  
                                                                                
                                                                                
                        Non-GAAP Financial Measurements                         
                                                                                
In addition to the GAAP results provided throughout this document, Silicon Labs
has provided non-GAAP financial measurements on a basis excluding non-cash and
other charges and benefits. Details of these excluded items are presented in the
tables below, which reconcile the GAAP results to non-GAAP financial
measurements.

The non-GAAP financial measurements do not replace the presentation of Silicon
Labs’ GAAP financial results. These measurements provide supplemental
information to assist management and investors in analyzing Silicon Labs’
financial position and results of operations. Silicon Labs has chosen to provide
this information to investors to enable them to perform meaningful comparisons
of past, present and future operating results and as a means to emphasize the
results of core on-going operations.
        Unaudited Reconciliation of GAAP to Non-GAAP Financial Measures         
                                                                                
                     (In thousands, except per share data)                      
                                                                                
       T…                                                                       
       M…                                                                       
       E…                                                                       
       O…                                                                       
       3,                                                                       
       2…                                                                       
 ────────────────────────────────────────────────────────────────────────────── 
  …              G…           S…        I…                            N…        
  …    G…        P…           C…        A…        M…        N…        P…        
  …    M…        of           E…        A…        C…        M…        of        
  …              R…                                                   R…        
  …    $   2…                                                                   
  …        1…        6…  %    $   4…    $    —    $    —    $   1…        …  %  
  …                                                                             
  …                                                                             
  …        9…        3…  %        1…        2…        3…        7…        …  %  
  …                                                                             
  …                                                                             
  …        5…        2…  %        1…         —        3…        3…        …  %  
  …                                                                             
  …                                                                             
  …        1…        5…  %        2…        2…        6…        1…        …  %  
  …                                                                             
  …        7…        3…  %        2…        2…        6…        4…        …  %  
  …                                                                             
                                                                                
                                                                                
       Th…                                                                      
       Mo…                                                                      
       En…                                                                      
       Oc…                                                                      
       3,                                                                       
       20…                                                                      
 ────────────────────────────────────────────────────────────────────────────── 
  …                    S…         I…                    I…             No…      
  …    GA…             C…         A…         M…         T…             GA…      
  …    Me…             E…         A…         C…         A…             Me…      
  …                                                                             
  …                                                                             
  …    $    8…         $   23…    $   2,…    $   6,…    $   -5…        $    3…  
  …                                                                             
  …                                                                             
  …             33…                                              3…             
  …                                                                             
  …                                                                             
  …    $    0…                                                         $    1…  
  …                                                                             
  …                                                                             
                                                                                
* Represents pre-tax amounts

** Represents the application of an 18% non-GAAP tax rate
                                                                                
                           Silicon Laboratories Inc.                            
                                                                                
                                                                                
                     Condensed Consolidated Balance Sheets                      
                                                                                
                     (In thousands, except per share data)                      
                                                                                
                                  (Unaudited)                                   
                                                                             
                                                October 3,       January 3,  
                                                      2026             2026  
 ─────────────────────────────────────────────────────────────────────────── 
  Assets                                                                     
  Current assets:                                                            
  Cash and cash equivalents                  $     423,013    $     364,222  
  Short-term investments                            16,828           79,400  
  Accounts receivable, net                          79,966           64,513  
  Inventories                                      133,391           95,566  
  Prepaid expenses and other current                71,421           70,316  
  assets                                                                     
  Total current assets                             724,619          674,017  
  Property and equipment, net                      131,687          128,643  
  Goodwill                                         376,389          376,389  
  Other intangible assets, net                      16,246           23,130  
  Other assets, net                                 87,213           67,138  
  Total assets                               $   1,336,154    $   1,269,317  
  Liabilities and Stockholders’ Equity                                       
  Current liabilities:                                                       
  Accounts payable                           $      68,860    $      50,717  
  Deferred revenue and returns liability             9,804            5,359  
  Other current liabilities                         78,841           87,711  
  Total current liabilities                        157,505          143,787  
  Other non-current liabilities                     53,267           31,112  
  Total liabilities                                210,772          174,899  
  Commitments and contingencies                                              
  Stockholders’ equity:                                                      
  Preferred stock – $0.0001 par value;                                       
  10,000 shares authorized; no shares                    —                —  
  issued                                                                     
  Common stock – $0.0001 par value;                                          
  250,000 shares authorized; 33,384 and                                      
  32,955 shares issued and outstanding at                3                3  
  October 3, 2026 and January 3, 2026,                                       
  respectively                                                               
  Additional paid-in capital                       206,203          157,402  
  Retained earnings                                919,176          936,814  
  Accumulated other comprehensive income                 —              199  
  Total stockholders’ equity                     1,125,382        1,094,418  
  Total liabilities and stockholders’        $   1,336,154    $   1,269,317  
  equity                                                                     
                                                                             
                                                                                
                           Silicon Laboratories Inc.                            
                                                                                
                                                                                
                Condensed Consolidated Statements of Cash Flows                 
                                                                                
                                 (In thousands)                                 
                                                                                
                                  (Unaudited)                                   
                                                                                
                                                   October 3,       October 4,  
                                Nine Months Ended        2026             2025  
 ────────────────────────────────────────────────────────────────────────────── 
  Operating Activities                                                          
  Net loss                      $                     -17,638    $     -62,223  
  Adjustments to reconcile                                                      
  net loss to net                                                               
  cash provided by operating                                                    
  activities:                                                                   
  Depreciation of property                             18,154           18,769  
  and equipment                                                                 
  Amortization of other                                 6,884           11,074  
  intangible assets                                                             
  Stock-based compensation                             69,754           59,645  
  expense                                                                       
  Deferred income taxes                                 2,164            2,026  
  Changes in operating                                                          
  assets and                                                                    
  liabilities:                                                                  
  Accounts receivable                                 -15,453          -12,829  
  Inventories                                         -37,828           23,316  
  Prepaid expenses and other                          -35,213            9,080  
  assets                                                                        
  Accounts payable                                     18,373           11,141  
  Other current liabilities                                                     
  and income                                            3,271           29,901  
  taxes                                                                         
  Deferred revenue and                                  4,445            5,374  
  returns liability                                                             
  Other non-current                                    20,285           -7,916  
  liabilities                                                                   
  Net cash provided by                                                          
  operating                                            37,198           87,358  
  activities                                                                    
  Investing Activities                                                          
  Purchases of marketable                                   —          -34,790  
  securities                                                                    
  Sales of marketable                                       —           15,332  
  securities                                                                    
  Maturities of marketable                             62,309           22,598  
  securities                                                                    
  Purchases of property and                           -28,472          -19,942  
  equipment                                                                     
  Proceeds from                                                                 
  capital-related government                            8,705                —  
  incentives                                                                    
  Purchase of other                                         —           -4,000  
  investment                                                                    
  Net cash provided by (used                                                    
  in) investing                                        42,542          -20,802  
  activities                                                                    
  Financing Activities                                                          
  Payment of taxes withheld                                                     
  for vested                                          -28,710          -14,907  
  stock awards                                                                  
  Proceeds from the issuance                                                    
  of common                                             7,761            8,147  
  stock                                                                         
  Net cash used in financing                          -20,949           -6,760  
  activities                                                                    
  Increase in cash and cash                            58,791           59,796  
  equivalents                                                                   
  Cash and cash equivalents                                                     
  at beginning                                        364,222          281,607  
  of period                                                                     
  Cash and cash equivalents                                                     
  at end of                     $                     423,013    $     341,403  
  period                                                                        
                                                                                

Sources

The 8-K item 2.02 filings (SEC EDGAR) and their EX-99 exhibits: the results release and, when filed, prepared remarks or the call transcript.

Also

Said vs did: the targets in these releases against what was then reported. Filings: every filing.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/SLAB/export.csv") into a cell.

Next:Presentations
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.